Alerus Financial’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-186
Closed -$8.92K – 547
2026
Q2
$8.92K Hold
186
– – ﹤0.01% 387
2026
Q1
$6.84K Hold
186
– – ﹤0.01% 402
2025
Q4
$9.46K Sell
186
-185
-50% -$9.46K ﹤0.01% 354
2025
Q3
$20.6K Buy
371
+185
+99% +$10.8K ﹤0.01% 318
2025
Q2
$12.8K Buy
+186
New +$12.7K ﹤0.01% 346

Other funds holding NVO

Alerus Financial's NVO Position: Q3 2026 in Review

Alerus Financial sold out of Novo Nordisk (NVO) in Q3 2026, closing a stake of 186 shares — an estimated $8.92K sold.

Alerus Financial first reported a position in NVO in Q2 2025 and held it in 5 quarters. The position peaked at $20.6K in Q3 2025. 1,232 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Alerus Financial reported no remaining Novo Nordisk position as of Q3 2026 after selling out during the quarter.
  • Alerus Financial sold 186 Novo Nordisk shares in Q3 2026, an estimated $8.92K.
  • Alerus Financial first reported a position in Novo Nordisk in Q2 2025 and held it in 5 quarters.
  • Alerus Financial's Novo Nordisk position peaked at $20.6K in Q3 2025.
  • 1,232 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Alerus Financial's 13F filing for Q3 2026, filed 9 Nov 2026.